As discussed extensively in our earlier review, inclusion of the cytoskeletal network mechano-transduction and myocyte sarcolemma stability provides a mechanism for the elevations of serum cTnI and cTnT in hypertension, heart failure, arrhythmias, exercise, and inotropic interventions [1]. This evidence concerns the gene TNNI3 and heart failure.